Verastem Eulerpool Nieuws

Verastem Aandeel Nieuws

Verastem wordt door vele journalisten en beleggers wereldwijd gevolgd. De meest actuele Verastem nieuwsberichten verzamelen we hier.

• 1 november ·

  Yahoo
  Verastem Oncology submits NDA for ovarian cancer treatment
• 31 oktober ·

  Yahoo
  Verastem Oncology Completes Rolling NDA Submission to the FDA for Avutometinib Plus Defactinib as a Treatment for Recurrent KRAS Mutant Low-Grade Serous Ovarian Cancer
• 31 oktober ·

  Yahoo
  Verastem Oncology to Participate in Upcoming Investor Conferences
• 31 oktober ·

  TipRanks
  Verastem completes rolling NDA submission to FDA for Avutometinib+Defactinib
• 21 oktober ·

  TipRanks
  Optimistic Buy Rating: Strong Phase 2 Results and Regulatory Progress for Verastem’s Avutometinib and Defactinib
• 17 oktober ·

  Benzinga
  12 Health Care Stocks Moving In Thursday's Intraday Session
• 17 oktober ·

  Yahoo
  Verastem Oncology Presents Positive Updated RAMP 201 Data for Avutometinib and Defactinib Combination in Recurrent Low-Grade Serous Ovarian Cancer at the International Gynecologic Cancer Society (IGCS) 2024 Annual Meeting
• 17 oktober ·

  Thefly.com
  Verastem presents updated data from RAMP 201 clinical trial
• 9 oktober ·

  Yahoo
  Verastem Oncology Announces Details for the Oral Presentation of the Mature RAMP 201 Data Evaluating Avutometinib Plus Defactinib in Recurrent Low-Grade Serous Ovarian Cancer at the IGCS 2024 Annual Meeting
• 7 oktober ·

  Yahoo
  Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)